Evaluation of Functional Outcomes and OCT-Biomarkers after Intravitreal Dexamethasone Implant for Postoperative Cystoid Macular Edema in Vitrectomized Eyes.

MLA

Freissinger, Sigrid, et al. “Evaluation of Functional Outcomes and OCT-Biomarkers after Intravitreal Dexamethasone Implant for Postoperative Cystoid Macular Edema in Vitrectomized Eyes.” Journal of Ophthalmology, vol. 2020, Apr. 2020, p. 3946531. EBSCOhost, https://doi.org/10.1155/2020/3946531.

APA

Freissinger, S., Vounotrypidis, E., Wolf, A., Kortuem, K. U., Shajari, M., Sakkias, F., Herold, T., Priglinger, S. G., & Mayer, W. J. (2020). Evaluation of Functional Outcomes and OCT-Biomarkers after Intravitreal Dexamethasone Implant for Postoperative Cystoid Macular Edema in Vitrectomized Eyes. Journal of Ophthalmology, 2020, 3946531. https://doi.org/10.1155/2020/3946531

Chicago

Freissinger, Sigrid, Efstathios Vounotrypidis, Armin Wolf, Karsten U Kortuem, Mehdi Shajari, Filippos Sakkias, Tina Herold, Siegfried G Priglinger, and Wolfgang J Mayer. 2020. “Evaluation of Functional Outcomes and OCT-Biomarkers after Intravitreal Dexamethasone Implant for Postoperative Cystoid Macular Edema in Vitrectomized Eyes.” Journal of Ophthalmology 2020 (April): 3946531. doi:10.1155/2020/3946531.